logo
Select company
Select metric
8.25%Free Cash Flow Yield
VS
Market
79
Sector
93
Industry
97
History
95
$ 34.65Close
$ 5.9 - $ 35.6 52-Week Range
Ticker Information

Ticker

STOK

Company Name

STOKE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

STOKE THERAPEUTICS INC - Free Cash Flow Yield Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

STOK - FCF Yield Historical data
DateFree Cash FlowFree Cash Flow YieldMarket Capitalization
6/30/2025$ 61.15M8.25%$ 741.41M
3/31/2025$ 69.2M14.19%$ 487.55M
12/31/2024$ -87.05M-18.15%$ 479.67M
9/30/2024$ -84.7M-12.25%$ 691.22M
6/30/2024$ -80.62M-11.17%$ 721.8M
3/31/2024$ -85.74M-13.86%$ 618.66M
12/31/2023$ -82.68M-27.47%$ 300.97M
9/30/2023$ -84.59M-39.06%$ 216.57M
6/30/2023$ -91.03M-35.16%$ 258.9M
3/31/2023$ -89M-18.79%$ 473.7M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • STOKE THERAPEUTICS INC's latest trailing twelve months (TTM) FCF Yield stands at -2.91%.
  • Over the past 5 years, STOKE THERAPEUTICS INC's average FCF Yield has been -10.33%.
  • The median FCF Yield for STOKE THERAPEUTICS INC during this period was -8.4%
  • STOKE THERAPEUTICS INC reached its highest FCF Yield over the past 5 years at 14.19%.
  • The lowest FCF Yield recorded by STOKE THERAPEUTICS INC in the same timeframe -39.06%

STOKE THERAPEUTICS INC's FCF Yield vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

FCF Yield Benchmarks
CompanyFCF Yield
AKBA : AKEBIA THERAPEUTICS INC -0.3%DAWN : DAY ONE BIOPHARMACEUTICALS INC -9.29%DNA : GINKGO BIOWORKS HOLDINGS INC -34.35%MRVI : MARAVAI LIFESCIENCES HOLDINGS INC -7.72%GERN : GERON CORP -20.1%KROS : KEROS THERAPEUTICS INC 9.07%NAGE : NIAGEN BIOSCIENCE INC 2.8%CRMD : CORMEDIX INC 3.77%IOVA : IOVANCE BIOTHERAPEUTICS INC -33.87%PHAT : PHATHOM PHARMACEUTICALS INC -41.22%

Definition of Free Cash Flow Yield

[Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
FCF / Market Cap
(=) FCF Yield
FCF Yield for STOKE THERAPEUTICS INC is calculated as follows: FCF [ $ -43.02M ] / Market Cap [ $ 1.48B ]
(=) FCF Yield [ -2.91% ]

STOK - Free Cash Flow Yield, Last 5 years

-39.06%

Minimum

Sep 30, 2023

14.19%

Maximum

Mar 31, 2025

-10.33%

Average

-8.4%

Median

FCF Yield Benchmark Analysis

The chart above depicts the distribution of FCF Yield for companies in the Total Stock Market. The average FCF Yield of the companies is 1.58% with a standard deviation of 11.38%.
The following table provides additional summary stats:
FCF Yield in the Market:
filtered constituents3.58K
min-33.87%
max37.55%
average1.58%
median3.22%
std11.38%